The Use of Virtual Reality During Breast Ultrasound-Guided Biopsy Procedures
VRBB
1 other identifier
interventional
60
1 country
1
Brief Summary
To determine if a virtual reality simulation will reduce pain and anxiety in patients undergoing an ultrasound guided breast biopsy procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 3, 2021
CompletedFirst Posted
Study publicly available on registry
September 13, 2021
CompletedStudy Start
First participant enrolled
September 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 7, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 7, 2022
CompletedApril 27, 2023
April 1, 2023
4 months
September 3, 2021
April 26, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Subjective Pain Assessment: Visual Analog Scale
Pain Measured with the Visual Analog Scale. Visual Analogue Scale (VAS) is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured. The individual will score their pain level by circling a number 0 - 10 both pre-operative and post-operatively. The scale range includes 0-10 scales, with \< 2 =well controlled, 2 - 5: partly controlled, \> 5: uncontrolled.
Immediate post-procedure
Secondary Outcomes (2)
State-Trait Anxiety Inventory (STAI: Y-6 item)
Immediate post-procedure
Patient Satisfaction
Immediate post-procedure
Other Outcomes (4)
Heart Rate
Immediate post-procedure
Temperature
Immediate post-procedure
Blood Volume Pulse Signal
Immediate post-procedure
- +1 more other outcomes
Study Arms (2)
Virtual Reality Goggles
EXPERIMENTALPatients randomized to the intervention group will undergo their procedure as standard of care but will wear the Oculus Go Goggles and experience a virtual reality simulation. The simulation is a non-interactive polar theme video.
Control
NO INTERVENTIONPatients randomized to the control group will undergo their procedure as standard of care without the use of virtual reality goggles.
Interventions
Oculus Go is a standalone portable Virtual Reality device that enables the user to immerse in different virtual environments. Non pharmacological technique to reduce pain and anxiety during a procedure.
Eligibility Criteria
You may qualify if:
- Informed consent is obtained from the patient
- Females who are 18 years of age
- Patient is scheduled for preoperative ultrasound guided breast biopsy procedure
You may not qualify if:
- Patient is scheduled for a stereotactic biopsy procedure
- The patient has motion sickness
- The patient has severe cognitive disabilities or language barriers that inhibit study form completion in English
- The patient has a history of seizures or epilepsy
- Refusal of patient to sign consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Prisma Health-Upstatelead
- Clemson Universitycollaborator
Study Sites (1)
Patewood Outpatient Surgery Center
Greenville, South Carolina, 29615, United States
Related Publications (11)
Breivik H, Borchgrevink PC, Allen SM, Rosseland LA, Romundstad L, Hals EK, Kvarstein G, Stubhaug A. Assessment of pain. Br J Anaesth. 2008 Jul;101(1):17-24. doi: 10.1093/bja/aen103. Epub 2008 May 16.
PMID: 18487245BACKGROUNDChirico A, Lucidi F, De Laurentiis M, Milanese C, Napoli A, Giordano A. Virtual Reality in Health System: Beyond Entertainment. A Mini-Review on the Efficacy of VR During Cancer Treatment. J Cell Physiol. 2016 Feb;231(2):275-87. doi: 10.1002/jcp.25117.
PMID: 26238976BACKGROUNDCosta WA, Monteiro MN, Queiroz JF, Goncalves AK. Pain and quality of life in breast cancer patients. Clinics (Sao Paulo). 2017 Dec;72(12):758-763. doi: 10.6061/clinics/2017(12)07.
PMID: 29319722BACKGROUNDHornblow AR, Kidson MA. The visual analogue scale for anxiety: a validation study. Aust N Z J Psychiatry. 1976 Dec;10(4):339-41. doi: 10.3109/00048677609159523. No abstract available.
PMID: 1071419BACKGROUNDMahrer NE, Gold JI. The use of virtual reality for pain control: a review. Curr Pain Headache Rep. 2009 Apr;13(2):100-9. doi: 10.1007/s11916-009-0019-8.
PMID: 19272275BACKGROUNDMalloy KM, Milling LS. The effectiveness of virtual reality distraction for pain reduction: a systematic review. Clin Psychol Rev. 2010 Dec;30(8):1011-8. doi: 10.1016/j.cpr.2010.07.001. Epub 2010 Jul 13.
PMID: 20691523BACKGROUNDBloomquist EV, Ajkay N, Patil S, Collett AE, Frazier TG, Barrio AV. A Randomized Prospective Comparison of Patient-Assessed Satisfaction and Clinical Outcomes with Radioactive Seed Localization versus Wire Localization. Breast J. 2016 Mar-Apr;22(2):151-7. doi: 10.1111/tbj.12564. Epub 2015 Dec 23.
PMID: 26696461RESULTPrice DD, McGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain. 1983 Sep;17(1):45-56. doi: 10.1016/0304-3959(83)90126-4.
PMID: 6226917RESULTRatcliff CG, Prinsloo S, Chaoul A, Zepeda SG, Cannon R, Spelman A, Yang WT, Cohen L. A Randomized Controlled Trial of Brief Mindfulness Meditation for Women Undergoing Stereotactic Breast Biopsy. J Am Coll Radiol. 2019 May;16(5):691-699. doi: 10.1016/j.jacr.2018.09.009. Epub 2018 Oct 12.
PMID: 30322793RESULTWalker MR, Kallingal GJ, Musser JE, Folen R, Stetz MC, Clark JY. Treatment efficacy of virtual reality distraction in the reduction of pain and anxiety during cystoscopy. Mil Med. 2014 Aug;179(8):891-6. doi: 10.7205/MILMED-D-13-00343.
PMID: 25102532RESULTWiederhold MD, Gao K, Wiederhold BK. Clinical use of virtual reality distraction system to reduce anxiety and pain in dental procedures. Cyberpsychol Behav Soc Netw. 2014 Jun;17(6):359-65. doi: 10.1089/cyber.2014.0203.
PMID: 24892198RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Drew Epling
Prisma Health-Upstate
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 3, 2021
First Posted
September 13, 2021
Study Start
September 15, 2021
Primary Completion
January 7, 2022
Study Completion
January 7, 2022
Last Updated
April 27, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share